Sleep and COVID-19. A Case Report of a Mild COVID-19 Patient Monitored by Consumer-Targeted Sleep Wearables

Since its first description in Wuhan, China, the novel Coronavirus (SARS-CoV-2) has spread rapidly around the world. The management of this major pandemic requires a close coordination between clinicians, scientists, and public health services in order to detect and promptly treat patients needing i...

Full description

Saved in:
Bibliographic Details
Published in:Sensors (Basel, Switzerland) Switzerland), 2021-12, Vol.21 (23), p.7944
Main Authors: Metlaine, Arnaud, Sauvet, Fabien, Chennaoui, Mounir, Leger, Damien, Elbaz, Maxime
Format: Article
Language:English
Subjects:
Case Report
Case reports
consumer sleep wearables
Coronaviruses
COVID-19
Disease transmission
Fever
Heart rate
Infections
Medical equipment
Monitoring
Pandemics
Patients
Physicians
Physiology
Public health
Severe acute respiratory syndrome coronavirus 2
sleep
Sleep deprivation
Sleep disorders
Telemedicine
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Since its first description in Wuhan, China, the novel Coronavirus (SARS-CoV-2) has spread rapidly around the world. The management of this major pandemic requires a close coordination between clinicians, scientists, and public health services in order to detect and promptly treat patients needing intensive care. The development of consumer wearable monitoring devices offers physicians new opportunities for the continuous monitoring of patients at home. This clinical case presents an original description of 55 days of SARS-CoV-2-induced physiological changes in a patient who routinely uses sleep-monitoring devices. We observed that sleep was specifically affected during COVID-19 (Total Sleep time, TST, and Wake after sleep onset, WASO), within a seemingly bidirectional manner. Sleep status prior to infection (e.g., chronic sleep deprivation or sleep disorders) may affect disease progression, and sleep could be considered as a biomarker of interest for monitoring COVID-19 progression. The use of habitual data represents an opportunity to evaluate pathologic states and improve clinical care.
ISSN:1424-8220
1424-8220
DOI:10.3390/s21237944